Cerebrospinal fluid fatty acid in Glucocerebrosidase-Associated Parkinson's Disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216275%3A25310%2F12%3A39895001" target="_blank" >RIV/00216275:25310/12:39895001 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Cerebrospinal fluid fatty acid in Glucocerebrosidase-Associated Parkinson's Disease

Popis výsledku v původním jazyce

Background: Heterozygous mutation in the glucocerebrosidase gene lead to an increased risk for and to more severe alpha-synuclein-associated pathology in Parkinson's disease. As both glucocerebrosidase and alpha-synuclein interact with fatty acids, we hypothesized that cerebrospinal fluid fatty acid level are altered in these Parkinson's patients. Methods: Cerebrospinal fluid levels of 13 fatty acids in 8 Parkinson's disease patients with a heterozygous glucocerebrosidase mutation were compared with those of 41 idiopathic Parkinson's disease patients and 30 controls using gas chromatography. Results: Parkinson's disease patients with a heterozygous glucocerebrosidase mutation had lover levels of palmitoleic acid (P= 0.007), oleic (P=0.016), linoleic (P=0.005), arachidonic (P=0.003), eicosapentaeneoic (P=0.003) and docosahexaenoic (P=0.03) acids and lower levels of total fatty acids (P=0.005) compared with both idiopathic Parkinson's disease patients and control subjects. Conclusions: T

Název v anglickém jazyce

Cerebrospinal fluid fatty acid in Glucocerebrosidase-Associated Parkinson's Disease

Popis výsledku anglicky

Background: Heterozygous mutation in the glucocerebrosidase gene lead to an increased risk for and to more severe alpha-synuclein-associated pathology in Parkinson's disease. As both glucocerebrosidase and alpha-synuclein interact with fatty acids, we hypothesized that cerebrospinal fluid fatty acid level are altered in these Parkinson's patients. Methods: Cerebrospinal fluid levels of 13 fatty acids in 8 Parkinson's disease patients with a heterozygous glucocerebrosidase mutation were compared with those of 41 idiopathic Parkinson's disease patients and 30 controls using gas chromatography. Results: Parkinson's disease patients with a heterozygous glucocerebrosidase mutation had lover levels of palmitoleic acid (P= 0.007), oleic (P=0.016), linoleic (P=0.005), arachidonic (P=0.003), eicosapentaeneoic (P=0.003) and docosahexaenoic (P=0.03) acids and lower levels of total fatty acids (P=0.005) compared with both idiopathic Parkinson's disease patients and control subjects. Conclusions: T

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Movement Disorders

ISSN

0885-3185

e-ISSN

—

Svazek periodika

27

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

5

Strana od-do

288-292

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—